Chirorab ≥ 2,5 IU/1,0 ml Freeze-dried powder and solvent for suspension for injection
PDF Leaflet Revision Date: 10 December 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation against rabies.
Dosage (summary)
1.0 ml IM for all ages; 0.1 ml ID for all ages.
Special Populations
- Paediatric patients
- Elderly patients
- Immunocompromised individuals
Pregnancy & Breastfeeding
Safe during pregnancy and breastfeeding when benefits outweigh risks.
Key Drug Interactions
- Immunosuppressive medicines
- Rabies immunoglobulin
Contraindications
- Hypersensitivity to vaccine components
- Acute diseases requiring treatment
Common side effects
- Injection site pain
- Headache
- Dizziness
- Nausea
- Rash
Counselling Points
- Monitor for allergic reactions
- Avoid mixing with other vaccines
- Follow local wound treatment guidelines
Serious warnings
- Anaphylactic reactions
- CNS effects like encephalitis
- Do not inject intravascularly
Important Disclaimer
The Chirorab ≥ 2,5 IU/1,0 ml Freeze-dried powder and solvent for suspension for injection professional information leaflet below is the property of Kahma Biotech and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
